Report ID: UCMIG35I2271
Report ID:
UCMIG35I2271 |
Region:
Global |
Published Date: Upcoming |
Pages:
165
| Tables: 55 | Figures: 60
In 2021, the global orphan drugs market showcased significant growth, reaching a substantial valuation of USD 152.3 billion. Projections for the near future are even more promising, with expectations that by 2030, the market will soar to approximately USD 438.9 billion. This remarkable expansion is underpinned by a robust compound annual growth rate (CAGR) of 12.48% throughout the forecast period from 2022 to 2030.
This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.
Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.
The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Pharmaceuticals by segment aggregation, the contribution of the Pharmaceuticals in Pharmaceuticals, Biotechnology & Life Sciences and vendor share.
To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONThe market for Orphan Drugs was estimated to be valued at US$ XX Mn in 2021.
The Orphan Drugs Market is estimated to grow at a CAGR of XX% by 2028.
The Orphan Drugs Market is segmented on the basis of Drug Type, Therapy, Distribution Channel, Geography.
Based on region, the Orphan Drugs Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
The key players operating in the Orphan Drugs Market are , F. Hoffmann-La Roche Ltd , Celgene Corporation , Merk & Co., Inc. , Novartis AG , Sanofi , Takeda Pharmaceutical Company Limited , AstraZeneca , Alexion Pharmaceuticals Inc. , Eli Lilly and Company , Amgen Inc..
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: UCMIG35I2271